Clinical Trial Update: Effects of Celecoxib After Percutaneous Coronary Intervention [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update evaluates the effects of celecoxib after percutaneous coronary intervention in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CELEBREX (Celecoxib)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Coronary Arteriosclerosis | Phase 4 | Status: COMPLETED